COVID-19 疾病对早期乳腺癌管理的影响：当前证据概述。
Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence.
机构信息
Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil.
Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo (USP), São Paulo, SP, Brazil.
出版信息
JCO Glob Oncol. 2022 May;8:e2100357. doi: 10.1200/GO.21.00357.
PURPOSE
An expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management.
METHODS
To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform.
RESULTS
This article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic.
CONCLUSION
This article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.
目的
成立了一个关于乳腺癌和 COVID-19 疾病的专家小组，以解决 COVID-19 大流行对早期乳腺癌（eBC）管理的影响。
方法
为了确保解决最具临床相关性的信息，从最新的几个国家和国际指南以及另一份技术文件中提取了基本信息。该专家小组于 2020 年 11 月至 2021 年 5 月期间举行了五次虚拟闭门会议，就循证结果的相关数据进行咨询。收集的数据在在线平台上进行了讨论。
结果
本文报告了专家小组对这些会议讨论的重点。此外，它还提供了涵盖在 COVID-19 大流行期间医疗保健专业人员在临床环境中常规遇到的 eBC 患者诊断、治疗和管理等主题的实用建议。
结论
本文就 COVID-19 大流行期间的 eBC 管理提供了指导，以告知更安全的护理实践。
Zotero 插件